Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Cerevel Therapeutics Hldng I

CUSIP: 15678U908 | 7 institutional holders

Quarters

Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023

Compare Detailed Historical Funds Options 13D/13G Peers Targeting Trading Summary Profile